Cargando…

Kinin B1 receptor: a potential therapeutic target in sepsis-induced vascular hyperpermeability

BACKGROUND: In sepsis, the endothelial barrier becomes incompetent, with the leaking of plasma into interstitial tissues. VE-cadherin, an adherens junction protein, is the gatekeeper of endothelial cohesion. Kinins, released during sepsis, induce vascular leakage and vasodilation. They act via two G...

Descripción completa

Detalles Bibliográficos
Autores principales: Ruiz, Stéphanie, Vardon-Bounes, Fanny, Buléon, Marie, Guilbeau-Frugier, Céline, Séguelas, Marie-Hélène, Conil, Jean-Marie, Girolami, Jean-Pierre, Tack, Ivan, Minville, Vincent
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7168845/
https://www.ncbi.nlm.nih.gov/pubmed/32306971
http://dx.doi.org/10.1186/s12967-020-02342-8
_version_ 1783523725909426176
author Ruiz, Stéphanie
Vardon-Bounes, Fanny
Buléon, Marie
Guilbeau-Frugier, Céline
Séguelas, Marie-Hélène
Conil, Jean-Marie
Girolami, Jean-Pierre
Tack, Ivan
Minville, Vincent
author_facet Ruiz, Stéphanie
Vardon-Bounes, Fanny
Buléon, Marie
Guilbeau-Frugier, Céline
Séguelas, Marie-Hélène
Conil, Jean-Marie
Girolami, Jean-Pierre
Tack, Ivan
Minville, Vincent
author_sort Ruiz, Stéphanie
collection PubMed
description BACKGROUND: In sepsis, the endothelial barrier becomes incompetent, with the leaking of plasma into interstitial tissues. VE-cadherin, an adherens junction protein, is the gatekeeper of endothelial cohesion. Kinins, released during sepsis, induce vascular leakage and vasodilation. They act via two G-protein coupled receptors: B1 (B1R) and B2 (B2R). B1R is inducible in the presence of pro-inflammatory cytokines, endotoxins or after tissue injury. It acts at a later stage of sepsis and elicits a sustained inflammatory response. The aim of our study was to investigate the relationships between B1R and VE-cadherin destabilization in vivo in a later phase of sepsis. METHODS: Experimental, prospective study in a university research laboratory. We used a polymicrobial model of septic shock by cecal ligation and puncture in C57BL6 male mice or C57BL6 male mice that received a specific B1R antagonist (R-954). We studied the influence of B1R on sepsis-induced vascular permeability 30 h after surgery for several organs, and VE-cadherin expression in the lung and kidneys by injecting R-954 just before surgery. The 96-h survival was determined in mice without treatment or in animals receiving R-954 as a “prophylactic” regimen (a subcutaneous injection of 200 µg/kg, prior to CLP and 24 h after CLP), or as a “curative” regimen (injection of 100 µg/kg at H6, H24 and H48 post-surgery). RESULTS: B1R inactivation helps to maintain MAP above 65 mmHg but induces different permeability profiles depending on whether or not organ perfusion is autoregulated. In our model, VE-cadherin was destabilized in vivo during septic shock. At a late stage of sepsis, the B1R blockade reduced the VE-cadherin disruption by limiting eNOS activation. The survival rate for mice that received R-954 after sepsis induction was higher than in animals that received an antagonist as a prophylactic treatment. CONCLUSIONS: B1R antagonizing reduced mortality in our model of murine septic shock by limiting the vascular permeability induced by VE-cadherin destabilization through maintenance of the macrohemodynamics, consequently limiting organ dysfunctions.
format Online
Article
Text
id pubmed-7168845
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-71688452020-04-23 Kinin B1 receptor: a potential therapeutic target in sepsis-induced vascular hyperpermeability Ruiz, Stéphanie Vardon-Bounes, Fanny Buléon, Marie Guilbeau-Frugier, Céline Séguelas, Marie-Hélène Conil, Jean-Marie Girolami, Jean-Pierre Tack, Ivan Minville, Vincent J Transl Med Research BACKGROUND: In sepsis, the endothelial barrier becomes incompetent, with the leaking of plasma into interstitial tissues. VE-cadherin, an adherens junction protein, is the gatekeeper of endothelial cohesion. Kinins, released during sepsis, induce vascular leakage and vasodilation. They act via two G-protein coupled receptors: B1 (B1R) and B2 (B2R). B1R is inducible in the presence of pro-inflammatory cytokines, endotoxins or after tissue injury. It acts at a later stage of sepsis and elicits a sustained inflammatory response. The aim of our study was to investigate the relationships between B1R and VE-cadherin destabilization in vivo in a later phase of sepsis. METHODS: Experimental, prospective study in a university research laboratory. We used a polymicrobial model of septic shock by cecal ligation and puncture in C57BL6 male mice or C57BL6 male mice that received a specific B1R antagonist (R-954). We studied the influence of B1R on sepsis-induced vascular permeability 30 h after surgery for several organs, and VE-cadherin expression in the lung and kidneys by injecting R-954 just before surgery. The 96-h survival was determined in mice without treatment or in animals receiving R-954 as a “prophylactic” regimen (a subcutaneous injection of 200 µg/kg, prior to CLP and 24 h after CLP), or as a “curative” regimen (injection of 100 µg/kg at H6, H24 and H48 post-surgery). RESULTS: B1R inactivation helps to maintain MAP above 65 mmHg but induces different permeability profiles depending on whether or not organ perfusion is autoregulated. In our model, VE-cadherin was destabilized in vivo during septic shock. At a late stage of sepsis, the B1R blockade reduced the VE-cadherin disruption by limiting eNOS activation. The survival rate for mice that received R-954 after sepsis induction was higher than in animals that received an antagonist as a prophylactic treatment. CONCLUSIONS: B1R antagonizing reduced mortality in our model of murine septic shock by limiting the vascular permeability induced by VE-cadherin destabilization through maintenance of the macrohemodynamics, consequently limiting organ dysfunctions. BioMed Central 2020-04-19 /pmc/articles/PMC7168845/ /pubmed/32306971 http://dx.doi.org/10.1186/s12967-020-02342-8 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Ruiz, Stéphanie
Vardon-Bounes, Fanny
Buléon, Marie
Guilbeau-Frugier, Céline
Séguelas, Marie-Hélène
Conil, Jean-Marie
Girolami, Jean-Pierre
Tack, Ivan
Minville, Vincent
Kinin B1 receptor: a potential therapeutic target in sepsis-induced vascular hyperpermeability
title Kinin B1 receptor: a potential therapeutic target in sepsis-induced vascular hyperpermeability
title_full Kinin B1 receptor: a potential therapeutic target in sepsis-induced vascular hyperpermeability
title_fullStr Kinin B1 receptor: a potential therapeutic target in sepsis-induced vascular hyperpermeability
title_full_unstemmed Kinin B1 receptor: a potential therapeutic target in sepsis-induced vascular hyperpermeability
title_short Kinin B1 receptor: a potential therapeutic target in sepsis-induced vascular hyperpermeability
title_sort kinin b1 receptor: a potential therapeutic target in sepsis-induced vascular hyperpermeability
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7168845/
https://www.ncbi.nlm.nih.gov/pubmed/32306971
http://dx.doi.org/10.1186/s12967-020-02342-8
work_keys_str_mv AT ruizstephanie kininb1receptorapotentialtherapeutictargetinsepsisinducedvascularhyperpermeability
AT vardonbounesfanny kininb1receptorapotentialtherapeutictargetinsepsisinducedvascularhyperpermeability
AT buleonmarie kininb1receptorapotentialtherapeutictargetinsepsisinducedvascularhyperpermeability
AT guilbeaufrugierceline kininb1receptorapotentialtherapeutictargetinsepsisinducedvascularhyperpermeability
AT seguelasmariehelene kininb1receptorapotentialtherapeutictargetinsepsisinducedvascularhyperpermeability
AT coniljeanmarie kininb1receptorapotentialtherapeutictargetinsepsisinducedvascularhyperpermeability
AT girolamijeanpierre kininb1receptorapotentialtherapeutictargetinsepsisinducedvascularhyperpermeability
AT tackivan kininb1receptorapotentialtherapeutictargetinsepsisinducedvascularhyperpermeability
AT minvillevincent kininb1receptorapotentialtherapeutictargetinsepsisinducedvascularhyperpermeability